Wordt geladen...
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
Schizophrenia is, in part, a cognitive illness. There are no approved medications for cognitive impairments associated with schizophrenia (CIAS) and primary negative symptoms. Cholinergic and glutamatergic systems, alpha-7 nicotinic acetylcholine (α-7nACh) and N-methyl-D-aspartate (NMDA) receptors,...
Bewaard in:
| Gepubliceerd in: | Mol Neuropsychiatry |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6323397/ https://ncbi.nlm.nih.gov/pubmed/30643787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000494495 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|